We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Norwegian Cruise Line
NCLH
$8.82B
| $2.97M | 0.01% |
115,400
+3,800
| +3% | +$96.1K |
|
552
Regal Rexnord
RRX
$11.5B
| $2.96M | 0.01% |
19,114
+3,500
| +22% | +$591K |
|
553
Incyte
INCY
$24.4B
| $2.94M | 0.01% |
42,600
-43,717
| -51% | -$3.12M |
|
554
Qiagen
QGEN
$8.91B
| $2.92M | 0.01% |
63,782
-7,486
| -11% | -$335K |
|
555
Ally Financial
ALLY
$13.6B
| $2.92M | 0.01% |
81,100
+22,200
| +38% | +$806K |
|
556
Jones Lang LaSalle
JLL
$16.8B
| $2.92M | 0.01% |
11,518
-100
| -0.9% | -$26.6K |
|
557
Lincoln Electric
LECO
$15.3B
| $2.91M | 0.01% |
15,516
-1,400
| -8% | -$282K |
|
558
Carlyle Group
CG
$17.7B
| $2.89M | 0.01% |
57,300
-5,500
| -9% | -$279K |
|
559
IonQ
IONQ
$18.5B
| $2.89M | 0.01% |
69,200
| – | – |
|
560
Equity Lifestyle Properties
ELS
$12.6B
| $2.87M | 0.01% |
43,118
-6,800
| -14% | -$471K |
|
561
American Airlines Group
AAL
$9.97B
| $2.87M | 0.01% |
164,700
+30,000
| +22% | +$431K |
|
562
Floor & Decor
FND
$6.3B
| $2.87M | 0.01% |
28,800
+4,800
| +20% | +$516K |
|
563
ITT
ITT
$19.3B
| $2.84M | 0.01% |
19,900
+2,900
| +17% | +$434K |
|
564
Tenet Healthcare
THC
$21.4B
| $2.81M | 0.01% |
22,218
-2,400
| -10% | -$357K |
|
565
Assurant
AIZ
$13.9B
| $2.77M | 0.01% |
13,000
-700
| -5% | -$146K |
|
|
EXAS
566
DELISTED
Exact Sciences
EXAS
| $2.77M | 0.01% |
49,200
+600
| +1% | +$37.3K |
|
567
Annaly Capital Management
NLY
$17.6B
| $2.76M | 0.01% |
150,600
+26,600
| +21% | +$520K |
|
568
Omega Healthcare
OHI
$14B
| $2.75M | 0.01% |
72,713
+7,800
| +12% | +$312K |
|
|
DAY
569
DELISTED
Dayforce
DAY
| $2.75M | 0.01% |
37,800
| – | – |
|
570
CubeSmart
CUBE
$9.41B
| $2.74M | 0.01% |
63,934
-7,100
| -10% | -$340K |
|
571
Tetra Tech
TTEK
$9.18B
| $2.72M | 0.01% |
68,345
+5,300
| +8% | +$238K |
|
572
BellRing Brands
BRBR
$1.27B
| $2.72M | 0.01% |
36,080
+600
| +2% | +$42.6K |
|
|
IPG
573
DELISTED
Interpublic Group of Companies
IPG
| $2.71M | 0.01% |
96,900
+3,700
| +4% | +$110K |
|
574
Erie Indemnity
ERIE
$13.3B
| $2.71M | 0.01% |
6,565
-200
| -3% | -$89.5K |
|
575
First Horizon
FHN
$12.3B
| $2.68M | 0.01% |
133,119
| – | – |
|
Similar funds
VIA
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.